(Q42257495)

19 October 2017

Fluphenazine pharmacokinetics and therapeutic response (English)

1 reference

19 October 2017

1 reference

1 reference

M W Dysken

1

1 reference

19 October 2017

J I Javaid

2

1 reference

19 October 2017

S S Chang

3

1 reference

19 October 2017

C Schaffer

4

1 reference

19 October 2017

A Shahid

5

1 reference

19 October 2017

J M Davis

6

1 reference

19 October 2017

language of work or name

1 reference

1 January 1981

1 reference

19 October 2017

1 reference

19 October 2017

73

1 reference

19 October 2017

3

1 reference

19 October 2017

205-210

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00422403

19 October 2017

0 references

cites work

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

https://api.crossref.org/works/10.1007%2FBF00422403

Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00422403

The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00422403

High plasma nortriptyline levels in the treatment of depression. I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00422403

Blood Levels of Neuroleptic Drugs in Nonresponding Chronic Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00422403

Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment

21 January 2018

1 reference

12 December 2020

Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels

1 reference

12 December 2020

Effect of antiparkinsonian medication on plasma levels of chlorpromazine

1 reference

12 December 2020

Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions

1 reference

12 December 2020

Plasma Level Monitoring of Antipsychotic Drugs

1 reference

12 December 2020

Determination of antipsychotic drugs by gas-liquid chromatography with a nitrogen detector using a simple acetylation technique

1 reference

12 December 2020

Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia

1 reference

12 December 2020

Monitoring plasma concentrations of neuroleptics

1 reference

12 December 2020

Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man

1 reference

12 December 2020

Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios

1 reference

12 December 2020

Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine

1 reference

12 December 2020

The possible role of metabolites in therapeutic response to chlorpromazine treatment

1 reference

12 December 2020

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

1 reference

12 December 2020

Measurement of fluphenazine by gas chromatography in human plasma and red blood cells

1 reference

12 December 2020

Mass fragmentography. Identification of chlorpromazine and its metabolites in human blood by a new method

1 reference

12 December 2020

Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis

1 reference

12 December 2020

Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector

1 reference

12 December 2020

Plasma levels of nortriptyline in the treatment of endogenous depression

1 reference

12 December 2020

Prediction of response to chlorpromazine treatment in schizophrenics

1 reference

12 December 2020

Letter: The effect of benztropine mesylate on plasma levels of butaperazine maleate.

1 reference

12 December 2020

Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment

1 reference

12 December 2020

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

1 reference

12 December 2020

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

1 reference

12 December 2020

Chlorpromazine Plasma Levels and Effects

1 reference

12 December 2020

Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo

1 reference

12 December 2020

Nortriptyline plasma levels and therapeutic response

1 reference

12 December 2020

Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature

1 reference

12 December 2020

Relationship between antidepressant effect and plasma level of nortriptyline. Clinical studies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00422403

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference